C.Surgical Procedure; Cardiac Clinical Trial
Official title:
Prospective, Randomised, Controlled Investigation Comparing the Safety and Performance of 032-11 Surgical Haemostat With FLOSEAL® Haemostatic Matrix in Cardiac Surgery and Thoracic Aortic Surgery.
NCT number | NCT01879475 |
Other study ID # | CT001 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | June 13, 2013 |
Last updated | April 6, 2015 |
Start date | June 2013 |
The effectiveness objective of this study is to evaluate whether 032-11 is non-inferior to Floseal as an adjunct to achieving haemostasis during surgical procedures involving cardiac and aortic thoracic surgery.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | |
Est. primary completion date | October 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - The patient must be equal or greater than 18 years old - The patient must have elective or non-elective urgent cardiac surgery or thoracic aortic surgery - The patient must have no childbearing potential or have a negative serum or urine pregnancy test within 7 days of the planned surgery or in the opinion of the Investigator performs adequate contraception - The patient is willing and able to be contacted for the follow-up visit at 6- 8 weeks - The patient must provide written informed consent using a form that is reviewed and approved by the IEC Exclusion Criteria: - The patient is currently enrolled in this or another investigational device or drug trial that has not completed the required follow up period. - The patient has a known hypersensitivity to materials of bovine origin - The patient does not wish to receive materials of bovine or shellfish origin for any reason |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United Kingdom | Hull and East Yorkshire Hospitals NHS Trust | Hull | East Yorkshire |
Lead Sponsor | Collaborator |
---|---|
Medtrade | The Clinical Trial Company |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Haemostasis success | Proportion of patients achieving haemostasis success following the first application of compression. | Intra-operative | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02908009 -
A Case Control Study to Identify the Role of Epigenetic Regulation of Genes Responsible for Energy Metabolism and Mitochondrial Function in the Obesity Paradox in Cardiac Surgery
|
||
Completed |
NCT01998438 -
Prospective Trial of Tranexamic Acid in Cardiac Surgery
|
Phase 4 | |
Completed |
NCT01805466 -
Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO)
|
N/A | |
Completed |
NCT02571920 -
Hemodynamic Monitoring, Positive Inotropic and Vasoactive Drugs During Cardiac Surgery (EMOA)
|
N/A | |
Completed |
NCT02658006 -
Evaluation of Monitoring TECHNOlogies in the PERI-OPerative Care of Cardiac Surgical Patients
|
N/A | |
Completed |
NCT02267538 -
Dexmedetomidine and Delirium in Patients After Cardiac Surgery
|
Phase 4 | |
Completed |
NCT02866825 -
Studying Complement Inhibition in Complex Cardiac Surgery
|
Phase 2 | |
Completed |
NCT02513862 -
Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery
|
N/A | |
Completed |
NCT02560519 -
Albumin in Cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT03884725 -
Fibrinogen Concentrate In Children Cardiac Surgery 2
|
Phase 4 | |
Completed |
NCT00598195 -
Ketamine Pharmacokinetics in Children Having Heart Surgery
|
N/A | |
Completed |
NCT02972684 -
Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass
|
N/A | |
Recruiting |
NCT02560285 -
High-risk Patients in Cardiac Surgery Procedures: HiriSCORE
|
N/A | |
Terminated |
NCT02793895 -
Detection of Atrial Fibrillation After Cardiac Surgery
|
N/A | |
Active, not recruiting |
NCT03343418 -
Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery
|
Phase 4 | |
Recruiting |
NCT03469440 -
Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery
|
N/A | |
Recruiting |
NCT03882593 -
Blood Cell Adhesion to Arterial Filters During Cardiac Surgery
|
||
Withdrawn |
NCT02119806 -
Decreasing the Incidence of Delirium After Cardiac Surgery
|
Phase 4 | |
Completed |
NCT02831907 -
Portal Flow Pulsatility as a Risk Factor for Acute Kidney Injury After Cardiac Surgery
|
N/A | |
Recruiting |
NCT02745951 -
HELIox CardiOPlegia Trial During Cardiac surgERy
|
N/A |